Tc-99m PMT whole-body scintigraphy for evaluation of therapeutic effect and for monitoring bone metastasis in a patient with hepatocellular carcinoma

被引：5

作者：

Sueyoshi, K ^{[1
]}

Narabayashi, I ^{[1
]}

Doi, K ^{[1
]}

Takahashi, M ^{[1
]}

Komori, T ^{[1
]}

Tatsu, Y ^{[1
]}

Tatsumi, T ^{[1
]}

Utunomiya, K ^{[1
]}

Uesugi, Y ^{[1
]}

Adachi, I ^{[1
]}

Shimizu, T ^{[1
]}

机构：

[1] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan

来源：

CLINICAL NUCLEAR MEDICINE | 2000年 / 25卷 / 12期

关键词：

bone metastases; bone scintigraphy; hepatocellular carcinoma; Tc-99m PMT whole-body scintigraphy;

D O I：

10.1097/00003072-200012000-00008

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Detection of metastatic lesions by bone scintigraphy is highly sensitive but has a low rate of specificity. Often bone metastases from hepatocellular carcinoma are not detected by bone scintigraphy because of low uptake or a photopenic area in the tumor. In contrast, Tc-99m Sn-N-pyridoxy-5-methyltryptophan (Tc-99m PMT) whole-body scintigraphy reflects tumor viability, and the specificity of detection is so high that tumor structure can be shown well. Tc-99m PMT whole-body scintigraphy was helpful for evaluating the response to therapy and monitoring the course of the patient described here with bone metastasis from hepatocellular carcinoma.

引用

页码：1000 / 1003

页数：4

共 50 条

[21] USE OF WHOLE-BODY RETENTION OF TC-99M DIPHOSPHONATE IN DIAGNOSIS OF METABOLIC BONE-DISEASE
FOGELMAN, I
BESSENT, RG
TURNER, JG
CITRIN, DL
BOYLE, IT
GREIG, WR
JOURNAL OF NUCLEAR MEDICINE, 1978, 19 (03) : 270 - 275
[22] USE OF WHOLE-BODY RETENTION OF TC-99M DIPHOSPHONATE IN DIAGNOSIS OF METABOLIC BONE-DISEASE
ARNOLD, JS
KHEDKAR, N
BARNES, WE
JOURNAL OF NUCLEAR MEDICINE, 1978, 19 (11) : 1273 - 1273
[23] WHOLE-BODY RETENTION OF TC-99M MPD IN PAGETS-DISEASE
VATTIMO, A
CANTALUPI, D
RIGHI, G
MARTINI, G
NUTI, R
TURCHETTI, V
JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1981, 25 (1-2): : 5 - 10
[24] WHOLE-BODY RETENTION OF TC-99M MDP IN VARIOUS SKELETAL DISEASES
ZORNBOPP, E
BULL, U
MUNZING, W
LANG, P
MOSER, EA
NUKLEARMEDIZIN, 1983, 22 (01) : 24 - 30
[25] BIODISTRIBUTION OF TC-99M SESTAMIBI IN RATS UTILIZING WHOLE-BODY AUTORADIOGRAPHY
COMBS, MJ
CROFT, BY
ARORA, J
TEATES, CD
JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P159 - P160
[26] SPLENIC METASTASIS OF HEPATOCELLULAR-CARCINOMA ACCUMULATION OF TC-99M HDP
FUJIMOTO, H
MURAKAMI, K
NOSAKA, K
ARIMIZU, N
CLINICAL NUCLEAR MEDICINE, 1992, 17 (02) : 99 - 100
[27] Dural metastasis demonstrated on Tc-99m MDP bone scintigraphy in staging workup for a patient with breast cancer
Truong, MX
Ting, ACC
Rossleigh, MA
Carroll, SL
CLINICAL NUCLEAR MEDICINE, 2006, 31 (04) : 223 - 224
[28] EVALUATION OF MAFFUCCI SYNDROME WITH TC-99M OXIDRONATE BONE-SCINTIGRAPHY
MCEWAN, JR
SLIZOFSKI, W
BROWN, SJ
KHAN, A
DADPARVAR, S
CLINICAL NUCLEAR MEDICINE, 1995, 20 (06) : 552 - 553
[29] Rapid changes in the scintigraphic pattern in Tc-99m DPD whole-body scanning in metabolic bone disease
Leitha, T
CLINICAL NUCLEAR MEDICINE, 1998, 23 (11) : 784 - 785
[30] THE 24-HOUR WHOLE-BODY RETENTION OF TC-99M DIPHOSPHONATE TECHNIQUE
FOGELMAN, I
BESSENT, RG
SMITH, ML
HART, DM
BOYLE, IT
SCOTTISH MEDICAL JOURNAL, 1983, 28 (04) : 399 - 399

← 1 2 3 4 5 →